Pleco Therapeutics BV logo

Pleco Therapeutics BV jobs and careers

About Pleco Therapeutics BV

Pleco Therapeutics' aim is to establish the market value and therapeutic potential of our patented PlecoidTM medications by focusing first on orphan cancer treatments. Current pre-clinical development activities at the firm are focused on the development of medicines for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, andSmall-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer. Both diseases carry a poor prognosis.

Founded in 2018 by Dan Gelvan, Gerben de Rijk, Ivo Timmermans and Rudi Jansen.

Founded
2018
Employees
1 to 10
Total funding
$17.3M

Leadership

The top of Pleco Therapeutics BV's org chart, with how many people report into each leader.

ITPhoto of Ivo Timmermans

Ivo Timmermans

Chief Executive Officer

3 reports

DGPhoto of Dan Gelvan

Dan Gelvan

Chief R&D Officer and co-founder

JPPhoto of Julie Powell

Julie Powell

Marketing and Communications Director

GRPhoto of Gerben de Rijk

Gerben de Rijk

Chief Legal Officer